UCLA Students Protest University Patent Claim On Prostate Cancer Treatment 13/03/2019 Divya Schlesinger Students at the University of California, Los Angeles (UCLA) renewed their protests today against a patent claim in an Indian High Court over a leading prostate cancer treatment, saying the claim, if successful, could make the drug unaffordable to millions of people in the developing world. Image Credits: Neda Ashtari. Continue reading -> Global Health Benefits Of Reaching Climate, Environment Targets Could Be US$ 54.1 Trillion – Says UN Report 12/03/2019 David Branigan The global health benefits of reducing air pollution and reaching the climate targets of the 2015 Paris Agreement could be as “high as $54.1 trillion dollars, at a cost of only $22.1 trillion,” according a new UN Environment analysis, to be released in full tomorrow. Image Credits: Wikimedia Commons. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Global Health Benefits Of Reaching Climate, Environment Targets Could Be US$ 54.1 Trillion – Says UN Report 12/03/2019 David Branigan The global health benefits of reducing air pollution and reaching the climate targets of the 2015 Paris Agreement could be as “high as $54.1 trillion dollars, at a cost of only $22.1 trillion,” according a new UN Environment analysis, to be released in full tomorrow. Image Credits: Wikimedia Commons. Continue reading -> High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
High Drug Prices Open Switzerland Up To Regional Procurement Ideas 07/02/2019 William New Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading -> The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The ‘Year Of UHC’ – Interview With Swiss Global Health Amb. Nora Kronig Romero 07/02/2019 Health Policy Watch Universal health coverage, access to medicines, and noncommunicable diseases are priorities for Switzerland in global health policy. Amb. Nora Kronig Romero is the head of the International Affairs Division and Vice Director General of the Federal Office of Public Health, as well as Swiss Ambassador for Global Health. She sat down with Health Policy Watch while in Geneva last week for the meeting of the World Health Organization Executive Board, which Switzerland attended as an observer to the governing board comprised of 34 WHO member states. Continue reading -> Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Civil Society Request Fair Pricing For Medicines, Transparency, At WHO 06/02/2019 Catherine Saez The fair pricing of medicines and the transparency of costs were underlined as key by many nongovernmental organisations last week during a discussion at the World Health Organization Executive Board on access to medicines. The Board heard about staggering numbers of people deprived of access to medication and health products, with examples from patients with epilepsy, kidney diseases and other illnesses preventing them from getting better or surviving their condition. Continue reading -> WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Board Hears Need For Palliative Care, Children Neglected By Medical Research 06/02/2019 Catherine Saez The World Health Organization Executive Board last week heard about what the lack of access to medicines and other health services has meant in real life. These ranged from the heart-wrenching story of a baby girl needing and getting pain-killing medication to ease her life and passing to bring attention to the need for palliative care, to millions of children not getting the treatment they need to treat tuberculosis or heart diseases. Continue reading -> Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Cancer Patients Need Greater Access To Pain Relief, Including Opioids, Says WHO 04/02/2019 Elaine Ruth Fletcher Cancer patients in developing countries often cannot get drugs for moderate and severe pain relief, due to the lack of access to opioid drugs. Access to cancer pain treatment needs to be eased, despite legitimate concerns about opioid abuse in some countries, says the World Health Organization (WHO). Continue reading -> Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Italy & United States: Remove Reference To Sugary Drink Tax From WHO NCDs Report 30/01/2019 Elaine Ruth Fletcher Representatives of Italy and the United States today asked the World Health Organization to remove a summary of evidence on how taxes on sugar-sweetened drinks may help reduce unhealthy sugar consumption from its latest progress report on tackling non-communicable disease (NCDs). Continue reading -> WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Member States Call For Transparency, Access To Innovation On Cancer Drug Pricing 30/01/2019 David Branigan A substantive discussion took place at the World Health Organization Executive Board meeting yesterday in response to a recently released WHO report on cancer drug pricing. Among the variety of perspectives expressed, many formed consensus in calling for increased transparency of research and development (R&D) costs and equitable access to innovative cancer drugs. Continue reading -> WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Executive Board Meeting: What Are The Hot Topics? 22/01/2019 Catherine Saez The World Health Organization Executive Board is being asked this week to consider a steep budget increase to cover the ambitious new “Transformation Plan” of Director General Tedros Adhanom Gheyebresus, which aims to improve the health of at least 3 billion people by 2025. The 8 percent budget hike requested for 2020-2021 will be reviewed by the Board along with a range of critical policy issues when it meets for its 144th session from 24 January-1 February. Here's what you need to know to follow the action. Continue reading -> Posts navigation Newer posts